ClinicalTrials.Veeva

Menu

Dealcoholized Muscadine Wine and Skin Health in Women

University of Florida logo

University of Florida

Status

Completed

Conditions

Skin Health

Treatments

Other: Control Beverage
Other: Dealcoholized Muscadine Wine

Study type

Interventional

Funder types

Other

Identifiers

NCT04614753
IRB202000789

Details and patient eligibility

About

The objective of this clinical trial is to determine the activity of dealcoholized muscadine wine to alleviate oxidative stress, inflammation, skin photoaging, and alter gut microbiome in women 40-67 years of age. The investigators hypothesize that dealcoholized muscadine wine daily for 42 days will significantly alleviate oxidative stress, inflammation, skin photoaging, and alter the gut microbiome in women compared to drinking sugar water.

Full description

Aging of the skin is characterized by wrinkling, sagging, and laxity. About 80% of facial skin aging is classified as extrinsic, or photoaging because it results from exposure to UV light of the sun that causes oxidative stress The remaining 20% of facial aging is the intrinsic type which is partially caused by the accumulation of proteins that are modified by reactive carbonyls in a reaction known as protein glycation. Aging also shifts the composition of the gut microbiome in at least 35 genera towards an unhealthy state of dysbiosis.

Previous studies showed that muscadine polyphenols inhibited protein glycation under a simulated physiological condition. Additional experiments using cell culture and mice showed that dealcoholized muscadine wine alleviated inflammation and protected against dysbiosis in the gut. The objective of this research is to confirm the health benefits of muscadine wine polyphenols in a clinical trial. The investigators hypothesize that dealcoholized muscadine wine consumption in women 40-65 years old will alleviate skin photoaging and skin conditions by decreasing oxidative stress and inflammation. It is also expected to improve the composition of the gut microbiome.

Enrollment

20 patients

Sex

Female

Ages

40 to 67 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy,
  • BMI 20.0-29.9
  • Fitzpatrick skin type 2 and 3.

Exclusion criteria

  • pregnancy
  • breast-feeding
  • smoking
  • alcohol use
  • history of skin cancer
  • intake of medication that might influence the outcome of the study
  • sunbathing or the use of tanning bed
  • intake of vitamin/mineral supplements

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

20 participants in 2 patient groups

Dealcoholized Muscadine Wine
Active Comparator group
Description:
Participants in this arm will receive 300ml of dealcoholized muscadine wine daily for six weeks. After a 7- day run-in period, participants will receive dealcoholized muscadine wine daily for six weeks
Treatment:
Other: Dealcoholized Muscadine Wine
Other: Control Beverage
Control Beverage
Active Comparator group
Description:
Participants in this arm will receive 300 ml of sugar water and acid content for six weeks. After a 7-day run in period, participants will receive sugar water for six weeks.
Treatment:
Other: Dealcoholized Muscadine Wine
Other: Control Beverage

Trial contacts and locations

1

Loading...

Central trial contact

Liwei Gu, PhD; Lindsey M Christman, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems